The Week2d
How innovations in CAR T-Cell therapy pave way for broader and safer cancer treatment
To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...
Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of ...
News Medical12h
CAR T cell therapy breakthroughs bring new hope for treating solid tumors
Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
VANCOUVER, British Columbia, November 07, 2024 -- ( BUSINESS WIRE )-- AbCellera (Nasdaq: ABCL) today announced new data on ...
Cure Today5d
FDA Approves CAR-T Cell Therapy for Relapsed or Refractory B-Cell ALL
The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...
Autolus secures FDA approval for CAR-T cell therapy use in ALL
Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...
technologynetworks6h
CAR T-Cell Therapy Fights Lethal Childhood Brain Cancer in Trial
A Stanford Medicine trial has shown success with CAR-T cell therapy in shrinking deadly childhood brain tumors. For one ...
Cell therapy fights lethal childhood brain cancer in clinical trial
An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...
GEN16h
CAR T-Cell Therapy Shows Efficacy in Young Patients with Incurable Brain Cancer
Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.